A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Status:
Recruiting
Trial end date:
2023-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the study drug, tirzepatide administered once weekly,
is safe and effective as a treatment for Nonalcoholic Steatohepatitis (NASH).